Effect of the Jeffries simulation framework on the core competence ofNew graduate pediatric surgery nurses: A prospective study

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Newly graduated pediatric surgery nurses must be able to identify and handle potential risks to ensure patient safety. It is necessary to reinforce their understanding of their roles and responsibilities to achieve this goal. However, the limitations of traditional classroom-based teaching hinder the exploration of learners' potential. Objectives This study aimed to evaluate the effectiveness of the Jeffries simulation framework in improving the core competence of new graduate nurses in pediatric surgery. Method A prospective methodology with a pretest/posttest design was used. The study involved 60 new graduate pediatric nurses who work in the pediatric surgery department of a level A tertiary hospital in Southwest China. Clinical scenario simulation cases, which were designed based on the Jeffries simulation framework, were used to improve clinical competence. Before and after the training, teachers assessed each nurse's core competency and clinical decision-making ability by the Chinese Registered Nurse Core Competency Scale (CIRN) and the Clinical Decision-Making in Nursing Scale (CDMNS). Results All 60 new graduate pediatric surgery nurses showed significant improvement in their clinical competence after undergoing simulation training (P < 0.001). Their core competence increased by 15 ± 0.32 points, while their clinical decision-making ability increased by 7.23 ± 4.17 points on average. Moreover, the dimensions of "clinical nursing", "professional development", "critical thinking/scientific" and "clear goals and values" also showed significant improvements. Conclusion Training new graduate pediatric nurses via the Jeffries simulation framework can enhance their clinical competence. Trial registration This study was registered on March 18, 2024, in the Chinese Clinical Trial Registry (ChiCTR2400082003) as part of our ongoing study.

Article activity feed